Clinical Trial Update: Observatory to Assess the Yukon Choice PC & the Yukon Chrome PC Sirolimus Eluting Bioabsorbable Polymer Stents Systems

View source ↗

Summary

Clinical trial update from Translumina GmbH noting an observatory study to assess Yukon Choice PC and Yukon Chrome PC sirolimus-eluting bioabsorbable polymer st…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease

Drugs mentioned

• Yukon Choice PC Sirolimus-Eluting Bioabsorbable Polymer Stent (Sirolimus-eluting bioabsorbable polymer stent)
• Yukon Chrome PC Sirolimus-Eluting Bioabsorbable Polymer Stent (Sirolimus-eluting bioabsorbable polymer stent)

Snippet

Sponsor: Translumina GmbH | Conditions: Coronaropathy | Status: ACTIVE_NOT_RECRUITING